267 related articles for article (PubMed ID: 27252512)
1. Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia.
Rampal R; Figueroa ME
Haematologica; 2016 Jun; 101(6):672-9. PubMed ID: 27252512
[TBL] [Abstract][Full Text] [Related]
2. A review of the Wilms' tumor 1 gene (WT1) and its role in hematopoiesis and leukemia.
Algar E
J Hematother Stem Cell Res; 2002 Aug; 11(4):589-99. PubMed ID: 12201948
[TBL] [Abstract][Full Text] [Related]
3. The molecular pathogenesis of acute myeloid leukemia.
Steffen B; Müller-Tidow C; Schwäble J; Berdel WE; Serve H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):195-221. PubMed ID: 16236521
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
Zidan MA; Kamal Shaaban HM; Elghannam DM
Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
[TBL] [Abstract][Full Text] [Related]
5. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells.
Murata Y; Kudoh T; Sugiyama H; Toyoshima K; Akiyama T
FEBS Lett; 1997 Jun; 409(1):41-5. PubMed ID: 9199500
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
Newcombe AA; Gibson BES; Keeshan K
Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA and Acute Leukemia.
Cruz-Miranda GM; Hidalgo-Miranda A; Bárcenas-López DA; Núñez-Enríquez JC; Ramírez-Bello J; Mejía-Aranguré JM; Jiménez-Morales S
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744139
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism.
Kwon M; Martínez-Laperche C; Infante M; Carretero F; Balsalobre P; Serrano D; Gayoso J; Pérez-Corral A; Anguita J; Díez-Martín JL; Buño I
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1235-42. PubMed ID: 22281301
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Wilms' tumor gene (WT1) in human leukemias.
Miwa H; Beran M; Saunders GF
Leukemia; 1992 May; 6(5):405-9. PubMed ID: 1317488
[TBL] [Abstract][Full Text] [Related]
11. WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy.
Rein LA; Chao NJ
Expert Opin Investig Drugs; 2014 Mar; 23(3):417-26. PubMed ID: 24521058
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
Pronier E; Bowman RL; Ahn J; Glass J; Kandoth C; Merlinsky TR; Whitfield JT; Durham BH; Gruet A; Hanasoge Somasundara AV; Rampal R; Melnick A; Koche RP; Taylor BS; Levine RL
Blood; 2018 Sep; 132(12):1265-1278. PubMed ID: 30064973
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
[TBL] [Abstract][Full Text] [Related]
14. What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia.
Nakata J; Oji Y; Oka Y; Sugiyama H
Expert Rev Hematol; 2019 Apr; 12(4):211-213. PubMed ID: 30882253
[No Abstract] [Full Text] [Related]
15. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
16. Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs.
Lopotová T; Polák J; Schwarz J; Klamová H; Moravcová J
Blood Cells Mol Dis; 2012 Jun; 49(1):41-7. PubMed ID: 22555024
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.
Ishikawa Y; Kiyoi H; Naoe T
Leuk Res; 2011 May; 35(5):685-8. PubMed ID: 21256590
[TBL] [Abstract][Full Text] [Related]
18. [Increased Wilms tumor gene (WT1) expression preceded by hematological relapse in a patient with acute myelogenous leukemia].
Suzushima H; Tsurusaki T; Kawaguchi Y; Matsushita I; Sawada T; Kawano S; Nishimura H
Nihon Naika Gakkai Zasshi; 2000 Feb; 89(2):347-9. PubMed ID: 10756650
[No Abstract] [Full Text] [Related]
19. Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia.
Maharry SE; Walker CJ; Liyanarachchi S; Mehta S; Patel M; Bainazar MA; Huang X; Lankenau MA; Hoag KW; Ranganathan P; Garzon R; Blachly JS; Guttridge DC; Bloomfield CD; de la Chapelle A; Eisfeld AK
Cancer Discov; 2016 Sep; 6(9):1036-51. PubMed ID: 27354268
[TBL] [Abstract][Full Text] [Related]
20. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
